These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10524640)

  • 21. Induction of hepatic tissue-type plasminogen activator and type 1 plasminogen activator-inhibitor gene expressions and appearance of their translation products in the bile following acute liver injury in rats.
    Noguchi T; Matsuyama S; Akao M; Hagiwara H; Uno S; Seki T; Ariga T
    Thromb Res; 2001 Nov; 104(4):283-91. PubMed ID: 11728530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of fibrinolytic proteins in relation to DNA ploidy in prostate cancer.
    Plas E; Carroll VA; Jilch R; Mihaly J; Vesely M; Ulrich W; Pflüger H; Binder BR
    Int J Cancer; 1998 Oct; 78(3):320-5. PubMed ID: 9766566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression profiles of fibrinolytic components in nasal mucosa.
    Sejima T; Madoiwa S; Mimuro J; Sugo T; Ishida T; Ichimura K; Sakata Y
    Histochem Cell Biol; 2004 Jul; 122(1):61-73. PubMed ID: 15197554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors of the plasminogen activator system in human testis, as demonstrated by in-situ hybridization and immunohistochemistry.
    Gunnarsson M; Lecander I; Abrahamsson PA
    Mol Hum Reprod; 1999 Oct; 5(10):934-40. PubMed ID: 10508221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical localization of tissue-type plasminogen activator and type I plasminogen activator inhibitor in radicular cysts.
    Tsai CH; Weng SF; Yang LC; Huang FM; Chen YJ; Chang YC
    J Oral Pathol Med; 2004 Mar; 33(3):156-61. PubMed ID: 15128057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of plasminogen activation by TGF-beta in cultured human retinal endothelial cells.
    Wileman SM; Booth NA; Moore N; Redmill B; Forrester JV; Knott RM
    Br J Ophthalmol; 2000 Apr; 84(4):417-22. PubMed ID: 10729302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of tissue type and urokinase type plasminogen activators as well as plasminogen activator inhibitor type-1 and type-2 in human and rhesus monkey placenta.
    Hu ZY; Liu YX; Liu K; Byrne S; Ny T; Feng Q; Ockleford CD
    J Anat; 1999 Feb; 194 ( Pt 2)(Pt 2):183-95. PubMed ID: 10337950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concentration of plasminogen activators and inhibitor in the human endometrium at different phases of the menstrual cycle.
    Koh SC; Wong PC; Yuen R; Chua SE; Ng BL; Ratnam SS
    J Reprod Fertil; 1992 Nov; 96(2):407-13. PubMed ID: 1339823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endogenous plasminogen activator expression after embolic focal cerebral ischemia in mice.
    Ahn MY; Zhang ZG; Tsang W; Chopp M
    Brain Res; 1999 Aug; 837(1-2):169-76. PubMed ID: 10433999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative evaluation of the influence of ovarian steroids on plasminogen activators and inhibitors in human endometrial cells and trophoblasts.
    Ueyama M; Kasatori N; Urayama T; Maemura T; Yao Y; Shiraishi T; Saito S; Kubo H
    Thromb Res; 2002 Nov; 108(4):235-44. PubMed ID: 12617987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibrinolysis during normal pregnancy and severe preeclampsia relationships between plasma levels of plasminogen activators and inhibitors.
    Nakashima A; Kobayashi T; Terao T
    Gynecol Obstet Invest; 1996; 42(2):95-101. PubMed ID: 8878712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increasing expression of tissue plasminogen activator and plasminogen activator inhibitor type 2 in dog gingival tissues with progressive inflammation.
    Lindberg P; Kinnby B; Lecander I; Lang NP; Matsson L
    Arch Oral Biol; 2001 Jan; 46(1):23-31. PubMed ID: 11163592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The plasminogen-activation system in ovarian tumors.
    Pujade-Lauraine E; Lu H; Mirshahi S; Soria J; Soria C; Bernadou A; Kruithof EK; Lijnen HR; Burtin P
    Int J Cancer; 1993 Aug; 55(1):27-31. PubMed ID: 8344749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator.
    Sitter T; Toet K; Quax P; Kooistra T
    Kidney Int; 1999 Jan; 55(1):120-9. PubMed ID: 9893120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasminogen activator inhibitor 2 and urokinase-type plasminogen activator in plasma and leucocytes in patients with severe sepsis.
    Robbie LA; Dummer S; Booth NA; Adey GD; Bennett B
    Br J Haematol; 2000 May; 109(2):342-8. PubMed ID: 10848822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 expression by U-937 mononuclear phagocytes. Effects of 1 alpha, 25-dihydroxyvitamin D3 and phorbol ester.
    Gyetko MR; Webb AC; Sitrin RG
    J Immunol; 1988 Oct; 141(8):2693-8. PubMed ID: 3139763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of black cohosh on the plasminogen activator system in vascular smooth muscle cells.
    Lee DY; Roh CR; Kang YH; Choi D; Lee Y; Rhyu MR; Yoon BK
    Maturitas; 2013 Sep; 76(1):75-80. PubMed ID: 23827472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S
    Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasminogen activators and plasminogen activator inhibitors in synovial fluid. Difference between inflammatory joint disorders and osteoarthritis.
    Saxne T; Lecander I; Geborek P
    J Rheumatol; 1993 Jan; 20(1):91-6. PubMed ID: 8441174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and alpha(2)-macroglobulin receptor in human breast carcinomas.
    Christensen L; Wiborg Simonsen AC; Heegaard CW; Moestrup SK; Andersen JA; Andreasen PA
    Int J Cancer; 1996 May; 66(4):441-52. PubMed ID: 8635858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.